dbSNP Short Genetic Variations
Welcome to the Reference SNP (rs) Report
All alleles are reported in the Forward orientation. Click on the Variant Details tab for details on Genomic Placement, Gene, and Amino Acid changes. HGVS names are in the HGVS tab.
Reference SNP (rs) Report
This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.
rs1801166
Current Build 156
Released September 21, 2022
- Organism
- Homo sapiens
- Position
-
chr5:112839543 (GRCh38.p14) Help
The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.
- Alleles
- G>A / G>C / G>T
- Variation Type
- SNV Single Nucleotide Variation
- Frequency
-
C=0.005973 (1581/264690, TOPMED)C=0.004384 (1101/251162, GnomAD_exome)C=0.005696 (799/140272, GnomAD) (+ 13 more)
- Clinical Significance
- Reported in ClinVar
- Gene : Consequence
- APC : Stop Gained
- Publications
- 25 citations
- Genomic View
- See rs on genome
ALFA Allele Frequency
The ALFA project provide aggregate allele frequency from dbGaP. More information is available on the project page including descriptions, data access, and terms of use.
Population | Group | Sample Size | Ref Allele | Alt Allele |
---|---|---|---|---|
Total | Global | 114748 | G=0.993124 | C=0.006876 |
European | Sub | 96984 | G=0.99266 | C=0.00734 |
African | Sub | 4374 | G=0.9925 | C=0.0075 |
African Others | Sub | 174 | G=0.989 | C=0.011 |
African American | Sub | 4200 | G=0.9926 | C=0.0074 |
Asian | Sub | 3328 | G=1.0000 | C=0.0000 |
East Asian | Sub | 2672 | G=1.0000 | C=0.0000 |
Other Asian | Sub | 656 | G=1.000 | C=0.000 |
Latin American 1 | Sub | 790 | G=0.995 | C=0.005 |
Latin American 2 | Sub | 944 | G=0.995 | C=0.005 |
South Asian | Sub | 274 | G=1.000 | C=0.000 |
Other | Sub | 8054 | G=0.9957 | C=0.0043 |
Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").
DownloadStudy | Population | Group | Sample Size | Ref Allele | Alt Allele |
---|---|---|---|---|---|
TopMed | Global | Study-wide | 264690 | G=0.994027 | C=0.005973 |
gnomAD - Exomes | Global | Study-wide | 251162 | G=0.995616 | C=0.004384 |
gnomAD - Exomes | European | Sub | 135150 | G=0.994510 | C=0.005490 |
gnomAD - Exomes | Asian | Sub | 48994 | G=0.99904 | C=0.00096 |
gnomAD - Exomes | American | Sub | 34574 | G=0.99598 | C=0.00402 |
gnomAD - Exomes | African | Sub | 16250 | G=0.99477 | C=0.00523 |
gnomAD - Exomes | Ashkenazi Jewish | Sub | 10068 | G=0.99493 | C=0.00507 |
gnomAD - Exomes | Other | Sub | 6126 | G=0.9940 | C=0.0060 |
gnomAD - Genomes | Global | Study-wide | 140272 | G=0.994304 | C=0.005696 |
gnomAD - Genomes | European | Sub | 75956 | G=0.99369 | C=0.00631 |
gnomAD - Genomes | African | Sub | 42048 | G=0.99422 | C=0.00578 |
gnomAD - Genomes | American | Sub | 13658 | G=0.99634 | C=0.00366 |
gnomAD - Genomes | Ashkenazi Jewish | Sub | 3324 | G=0.9952 | C=0.0048 |
gnomAD - Genomes | East Asian | Sub | 3134 | G=1.0000 | C=0.0000 |
gnomAD - Genomes | Other | Sub | 2152 | G=0.9949 | C=0.0051 |
ExAC | Global | Study-wide | 121152 | G=0.995873 | C=0.004127 |
ExAC | Europe | Sub | 73242 | G=0.99474 | C=0.00526 |
ExAC | Asian | Sub | 25136 | G=0.99877 | C=0.00123 |
ExAC | American | Sub | 11546 | G=0.99723 | C=0.00277 |
ExAC | African | Sub | 10324 | G=0.99535 | C=0.00465 |
ExAC | Other | Sub | 904 | G=0.996 | C=0.004 |
Allele Frequency Aggregator | Total | Global | 114748 | G=0.993124 | C=0.006876 |
Allele Frequency Aggregator | European | Sub | 96984 | G=0.99266 | C=0.00734 |
Allele Frequency Aggregator | Other | Sub | 8054 | G=0.9957 | C=0.0043 |
Allele Frequency Aggregator | African | Sub | 4374 | G=0.9925 | C=0.0075 |
Allele Frequency Aggregator | Asian | Sub | 3328 | G=1.0000 | C=0.0000 |
Allele Frequency Aggregator | Latin American 2 | Sub | 944 | G=0.995 | C=0.005 |
Allele Frequency Aggregator | Latin American 1 | Sub | 790 | G=0.995 | C=0.005 |
Allele Frequency Aggregator | South Asian | Sub | 274 | G=1.000 | C=0.000 |
The PAGE Study | Global | Study-wide | 78698 | G=0.99558 | C=0.00442 |
The PAGE Study | AfricanAmerican | Sub | 32516 | G=0.99443 | C=0.00557 |
The PAGE Study | Mexican | Sub | 10810 | G=0.99648 | C=0.00352 |
The PAGE Study | Asian | Sub | 8318 | G=0.9998 | C=0.0002 |
The PAGE Study | PuertoRican | Sub | 7916 | G=0.9952 | C=0.0048 |
The PAGE Study | NativeHawaiian | Sub | 4534 | G=0.9976 | C=0.0024 |
The PAGE Study | Cuban | Sub | 4230 | G=0.9931 | C=0.0069 |
The PAGE Study | Dominican | Sub | 3826 | G=0.9948 | C=0.0052 |
The PAGE Study | CentralAmerican | Sub | 2450 | G=0.9939 | C=0.0061 |
The PAGE Study | SouthAmerican | Sub | 1982 | G=0.9965 | C=0.0035 |
The PAGE Study | NativeAmerican | Sub | 1260 | G=0.9944 | C=0.0056 |
The PAGE Study | SouthAsian | Sub | 856 | G=1.000 | C=0.000 |
1000Genomes_30x | Global | Study-wide | 6404 | G=0.9972 | C=0.0028 |
1000Genomes_30x | African | Sub | 1786 | G=0.9972 | C=0.0028 |
1000Genomes_30x | Europe | Sub | 1266 | G=0.9945 | C=0.0055 |
1000Genomes_30x | South Asian | Sub | 1202 | G=0.9975 | C=0.0025 |
1000Genomes_30x | East Asian | Sub | 1170 | G=1.0000 | C=0.0000 |
1000Genomes_30x | American | Sub | 980 | G=0.997 | C=0.003 |
1000Genomes | Global | Study-wide | 5008 | G=0.9970 | C=0.0030 |
1000Genomes | African | Sub | 1322 | G=0.9970 | C=0.0030 |
1000Genomes | East Asian | Sub | 1008 | G=1.0000 | C=0.0000 |
1000Genomes | Europe | Sub | 1006 | G=0.9940 | C=0.0060 |
1000Genomes | South Asian | Sub | 978 | G=0.997 | C=0.003 |
1000Genomes | American | Sub | 694 | G=0.997 | C=0.003 |
Genetic variation in the Estonian population | Estonian | Study-wide | 4480 | G=0.9993 | C=0.0007 |
The Avon Longitudinal Study of Parents and Children | PARENT AND CHILD COHORT | Study-wide | 3854 | G=0.9935 | C=0.0065 |
UK 10K study - Twins | TWIN COHORT | Study-wide | 3708 | G=0.9903 | C=0.0097 |
Genome of the Netherlands Release 5 | Genome of the Netherlands | Study-wide | 998 | G=0.994 | C=0.006 |
Medical Genome Project healthy controls from Spanish population | Spanish controls | Study-wide | 534 | G=0.993 | C=0.007 |
Qatari | Global | Study-wide | 216 | G=0.981 | C=0.019 |
SGDP_PRJ | Global | Study-wide | 2 | G=0.5 | C=0.5 |
Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.
Sequence name | Change |
---|---|
GRCh38.p14 chr 5 | NC_000005.10:g.112839543G>A |
GRCh38.p14 chr 5 | NC_000005.10:g.112839543G>C |
GRCh38.p14 chr 5 | NC_000005.10:g.112839543G>T |
GRCh37.p13 chr 5 | NC_000005.9:g.112175240G>A |
GRCh37.p13 chr 5 | NC_000005.9:g.112175240G>C |
GRCh37.p13 chr 5 | NC_000005.9:g.112175240G>T |
APC RefSeqGene (LRG_130) | NG_008481.4:g.152023G>A |
APC RefSeqGene (LRG_130) | NG_008481.4:g.152023G>C |
APC RefSeqGene (LRG_130) | NG_008481.4:g.152023G>T |
Molecule type | Change | Amino acid[Codon] | SO Term |
---|---|---|---|
APC transcript variant 3 | NM_000038.6:c.3949G>A | E [GAA] > K [AAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform b | NP_000029.2:p.Glu1317Lys | E (Glu) > K (Lys) | Missense Variant |
APC transcript variant 3 | NM_000038.6:c.3949G>C | E [GAA] > Q [CAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform b | NP_000029.2:p.Glu1317Gln | E (Glu) > Q (Gln) | Missense Variant |
APC transcript variant 3 | NM_000038.6:c.3949G>T | E [GAA] > * [TAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform b | NP_000029.2:p.Glu1317Ter | E (Glu) > * (Ter) | Stop Gained |
APC transcript variant 15 | NM_001354906.2:c.3100G>A | E [GAA] > K [AAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform m |
NP_001341835.1:p.Glu1034L… NP_001341835.1:p.Glu1034Lys |
E (Glu) > K (Lys) | Missense Variant |
APC transcript variant 15 | NM_001354906.2:c.3100G>C | E [GAA] > Q [CAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform m |
NP_001341835.1:p.Glu1034G… NP_001341835.1:p.Glu1034Gln |
E (Glu) > Q (Gln) | Missense Variant |
APC transcript variant 15 | NM_001354906.2:c.3100G>T | E [GAA] > * [TAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform m |
NP_001341835.1:p.Glu1034T… NP_001341835.1:p.Glu1034Ter |
E (Glu) > * (Ter) | Stop Gained |
APC transcript variant 13 | NM_001354904.2:c.3571G>A | E [GAA] > K [AAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform k |
NP_001341833.1:p.Glu1191L… NP_001341833.1:p.Glu1191Lys |
E (Glu) > K (Lys) | Missense Variant |
APC transcript variant 13 | NM_001354904.2:c.3571G>C | E [GAA] > Q [CAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform k |
NP_001341833.1:p.Glu1191G… NP_001341833.1:p.Glu1191Gln |
E (Glu) > Q (Gln) | Missense Variant |
APC transcript variant 13 | NM_001354904.2:c.3571G>T | E [GAA] > * [TAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform k |
NP_001341833.1:p.Glu1191T… NP_001341833.1:p.Glu1191Ter |
E (Glu) > * (Ter) | Stop Gained |
APC transcript variant 6 | NM_001354897.2:c.3979G>A | E [GAA] > K [AAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform d |
NP_001341826.1:p.Glu1327L… NP_001341826.1:p.Glu1327Lys |
E (Glu) > K (Lys) | Missense Variant |
APC transcript variant 6 | NM_001354897.2:c.3979G>C | E [GAA] > Q [CAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform d |
NP_001341826.1:p.Glu1327G… NP_001341826.1:p.Glu1327Gln |
E (Glu) > Q (Gln) | Missense Variant |
APC transcript variant 6 | NM_001354897.2:c.3979G>T | E [GAA] > * [TAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform d |
NP_001341826.1:p.Glu1327T… NP_001341826.1:p.Glu1327Ter |
E (Glu) > * (Ter) | Stop Gained |
APC transcript variant 11 | NM_001354902.2:c.3676G>A | E [GAA] > K [AAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform i |
NP_001341831.1:p.Glu1226L… NP_001341831.1:p.Glu1226Lys |
E (Glu) > K (Lys) | Missense Variant |
APC transcript variant 11 | NM_001354902.2:c.3676G>C | E [GAA] > Q [CAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform i |
NP_001341831.1:p.Glu1226G… NP_001341831.1:p.Glu1226Gln |
E (Glu) > Q (Gln) | Missense Variant |
APC transcript variant 11 | NM_001354902.2:c.3676G>T | E [GAA] > * [TAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform i |
NP_001341831.1:p.Glu1226T… NP_001341831.1:p.Glu1226Ter |
E (Glu) > * (Ter) | Stop Gained |
APC transcript variant 14 | NM_001354905.2:c.3469G>A | E [GAA] > K [AAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform l |
NP_001341834.1:p.Glu1157L… NP_001341834.1:p.Glu1157Lys |
E (Glu) > K (Lys) | Missense Variant |
APC transcript variant 14 | NM_001354905.2:c.3469G>C | E [GAA] > Q [CAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform l |
NP_001341834.1:p.Glu1157G… NP_001341834.1:p.Glu1157Gln |
E (Glu) > Q (Gln) | Missense Variant |
APC transcript variant 14 | NM_001354905.2:c.3469G>T | E [GAA] > * [TAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform l |
NP_001341834.1:p.Glu1157T… NP_001341834.1:p.Glu1157Ter |
E (Glu) > * (Ter) | Stop Gained |
APC transcript variant 4 | NM_001354895.2:c.3949G>A | E [GAA] > K [AAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform b |
NP_001341824.1:p.Glu1317L… NP_001341824.1:p.Glu1317Lys |
E (Glu) > K (Lys) | Missense Variant |
APC transcript variant 4 | NM_001354895.2:c.3949G>C | E [GAA] > Q [CAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform b |
NP_001341824.1:p.Glu1317G… NP_001341824.1:p.Glu1317Gln |
E (Glu) > Q (Gln) | Missense Variant |
APC transcript variant 4 | NM_001354895.2:c.3949G>T | E [GAA] > * [TAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform b |
NP_001341824.1:p.Glu1317T… NP_001341824.1:p.Glu1317Ter |
E (Glu) > * (Ter) | Stop Gained |
APC transcript variant 7 | NM_001354898.2:c.3874G>A | E [GAA] > K [AAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform e |
NP_001341827.1:p.Glu1292L… NP_001341827.1:p.Glu1292Lys |
E (Glu) > K (Lys) | Missense Variant |
APC transcript variant 7 | NM_001354898.2:c.3874G>C | E [GAA] > Q [CAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform e |
NP_001341827.1:p.Glu1292G… NP_001341827.1:p.Glu1292Gln |
E (Glu) > Q (Gln) | Missense Variant |
APC transcript variant 7 | NM_001354898.2:c.3874G>T | E [GAA] > * [TAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform e |
NP_001341827.1:p.Glu1292T… NP_001341827.1:p.Glu1292Ter |
E (Glu) > * (Ter) | Stop Gained |
APC transcript variant 5 | NM_001354896.2:c.4003G>A | E [GAA] > K [AAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform c |
NP_001341825.1:p.Glu1335L… NP_001341825.1:p.Glu1335Lys |
E (Glu) > K (Lys) | Missense Variant |
APC transcript variant 5 | NM_001354896.2:c.4003G>C | E [GAA] > Q [CAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform c |
NP_001341825.1:p.Glu1335G… NP_001341825.1:p.Glu1335Gln |
E (Glu) > Q (Gln) | Missense Variant |
APC transcript variant 5 | NM_001354896.2:c.4003G>T | E [GAA] > * [TAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform c |
NP_001341825.1:p.Glu1335T… NP_001341825.1:p.Glu1335Ter |
E (Glu) > * (Ter) | Stop Gained |
APC transcript variant 10 | NM_001354901.2:c.3772G>A | E [GAA] > K [AAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform h |
NP_001341830.1:p.Glu1258L… NP_001341830.1:p.Glu1258Lys |
E (Glu) > K (Lys) | Missense Variant |
APC transcript variant 10 | NM_001354901.2:c.3772G>C | E [GAA] > Q [CAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform h |
NP_001341830.1:p.Glu1258G… NP_001341830.1:p.Glu1258Gln |
E (Glu) > Q (Gln) | Missense Variant |
APC transcript variant 10 | NM_001354901.2:c.3772G>T | E [GAA] > * [TAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform h |
NP_001341830.1:p.Glu1258T… NP_001341830.1:p.Glu1258Ter |
E (Glu) > * (Ter) | Stop Gained |
APC transcript variant 9 | NM_001354900.2:c.3826G>A | E [GAA] > K [AAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform g |
NP_001341829.1:p.Glu1276L… NP_001341829.1:p.Glu1276Lys |
E (Glu) > K (Lys) | Missense Variant |
APC transcript variant 9 | NM_001354900.2:c.3826G>C | E [GAA] > Q [CAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform g |
NP_001341829.1:p.Glu1276G… NP_001341829.1:p.Glu1276Gln |
E (Glu) > Q (Gln) | Missense Variant |
APC transcript variant 9 | NM_001354900.2:c.3826G>T | E [GAA] > * [TAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform g |
NP_001341829.1:p.Glu1276T… NP_001341829.1:p.Glu1276Ter |
E (Glu) > * (Ter) | Stop Gained |
APC transcript variant 8 | NM_001354899.2:c.3865G>A | E [GAA] > K [AAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform f |
NP_001341828.1:p.Glu1289L… NP_001341828.1:p.Glu1289Lys |
E (Glu) > K (Lys) | Missense Variant |
APC transcript variant 8 | NM_001354899.2:c.3865G>C | E [GAA] > Q [CAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform f |
NP_001341828.1:p.Glu1289G… NP_001341828.1:p.Glu1289Gln |
E (Glu) > Q (Gln) | Missense Variant |
APC transcript variant 8 | NM_001354899.2:c.3865G>T | E [GAA] > * [TAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform f |
NP_001341828.1:p.Glu1289T… NP_001341828.1:p.Glu1289Ter |
E (Glu) > * (Ter) | Stop Gained |
APC transcript variant 12 | NM_001354903.2:c.3646G>A | E [GAA] > K [AAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform j |
NP_001341832.1:p.Glu1216L… NP_001341832.1:p.Glu1216Lys |
E (Glu) > K (Lys) | Missense Variant |
APC transcript variant 12 | NM_001354903.2:c.3646G>C | E [GAA] > Q [CAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform j |
NP_001341832.1:p.Glu1216G… NP_001341832.1:p.Glu1216Gln |
E (Glu) > Q (Gln) | Missense Variant |
APC transcript variant 12 | NM_001354903.2:c.3646G>T | E [GAA] > * [TAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform j |
NP_001341832.1:p.Glu1216T… NP_001341832.1:p.Glu1216Ter |
E (Glu) > * (Ter) | Stop Gained |
APC transcript variant 2 | NM_001127510.3:c.3949G>A | E [GAA] > K [AAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform b |
NP_001120982.1:p.Glu1317L… NP_001120982.1:p.Glu1317Lys |
E (Glu) > K (Lys) | Missense Variant |
APC transcript variant 2 | NM_001127510.3:c.3949G>C | E [GAA] > Q [CAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform b |
NP_001120982.1:p.Glu1317G… NP_001120982.1:p.Glu1317Gln |
E (Glu) > Q (Gln) | Missense Variant |
APC transcript variant 2 | NM_001127510.3:c.3949G>T | E [GAA] > * [TAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform b |
NP_001120982.1:p.Glu1317T… NP_001120982.1:p.Glu1317Ter |
E (Glu) > * (Ter) | Stop Gained |
APC transcript variant 1 | NM_001127511.3:c.3895G>A | E [GAA] > K [AAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform a |
NP_001120983.2:p.Glu1299L… NP_001120983.2:p.Glu1299Lys |
E (Glu) > K (Lys) | Missense Variant |
APC transcript variant 1 | NM_001127511.3:c.3895G>C | E [GAA] > Q [CAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform a |
NP_001120983.2:p.Glu1299G… NP_001120983.2:p.Glu1299Gln |
E (Glu) > Q (Gln) | Missense Variant |
APC transcript variant 1 | NM_001127511.3:c.3895G>T | E [GAA] > * [TAA] | Coding Sequence Variant |
adenomatous polyposis coli protein isoform a |
NP_001120983.2:p.Glu1299T… NP_001120983.2:p.Glu1299Ter |
E (Glu) > * (Ter) | Stop Gained |
Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.
ClinVar Accession | Disease Names | Clinical Significance |
---|---|---|
RCV000000872.22 | Familial adenomatous polyposis 1 | Conflicting-Interpretations-Of-Pathogenicity |
RCV000034389.23 | not provided | Conflicting-Interpretations-Of-Pathogenicity |
RCV000035073.25 | not specified | Benign |
RCV000322880.4 | APC-Associated Polyposis Disorders | Benign |
RCV000579405.5 | Hereditary cancer-predisposing syndrome | Benign-Likely-Benign |
RCV001353725.2 | Carcinoma of colon | Benign |
RCV001762027.2 | Colorectal cancer | Likely-Benign |
RCV002227982.4 | Familial adenomatous polyposis 1 | Benign |
Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".
Placement | G= | A | C | T |
---|---|---|---|---|
GRCh38.p14 chr 5 | NC_000005.10:g.112839543= | NC_000005.10:g.112839543G>A | NC_000005.10:g.112839543G>C | NC_000005.10:g.112839543G>T |
GRCh37.p13 chr 5 | NC_000005.9:g.112175240= | NC_000005.9:g.112175240G>A | NC_000005.9:g.112175240G>C | NC_000005.9:g.112175240G>T |
APC RefSeqGene (LRG_130) | NG_008481.4:g.152023= | NG_008481.4:g.152023G>A | NG_008481.4:g.152023G>C | NG_008481.4:g.152023G>T |
APC transcript variant 3 | NM_000038.6:c.3949= | NM_000038.6:c.3949G>A | NM_000038.6:c.3949G>C | NM_000038.6:c.3949G>T |
APC transcript variant 3 | NM_000038.5:c.3949= | NM_000038.5:c.3949G>A | NM_000038.5:c.3949G>C | NM_000038.5:c.3949G>T |
APC transcript variant 2 | NM_001127510.3:c.3949= | NM_001127510.3:c.3949G>A | NM_001127510.3:c.3949G>C | NM_001127510.3:c.3949G>T |
APC transcript variant 2 | NM_001127510.2:c.3949= | NM_001127510.2:c.3949G>A | NM_001127510.2:c.3949G>C | NM_001127510.2:c.3949G>T |
APC transcript variant 1 | NM_001127511.3:c.3895= | NM_001127511.3:c.3895G>A | NM_001127511.3:c.3895G>C | NM_001127511.3:c.3895G>T |
APC transcript variant 1 | NM_001127511.2:c.3895= | NM_001127511.2:c.3895G>A | NM_001127511.2:c.3895G>C | NM_001127511.2:c.3895G>T |
APC transcript variant 4 | NM_001354895.2:c.3949= | NM_001354895.2:c.3949G>A | NM_001354895.2:c.3949G>C | NM_001354895.2:c.3949G>T |
APC transcript variant 4 | NM_001354895.1:c.3949= | NM_001354895.1:c.3949G>A | NM_001354895.1:c.3949G>C | NM_001354895.1:c.3949G>T |
APC transcript variant 6 | NM_001354897.2:c.3979= | NM_001354897.2:c.3979G>A | NM_001354897.2:c.3979G>C | NM_001354897.2:c.3979G>T |
APC transcript variant 6 | NM_001354897.1:c.3979= | NM_001354897.1:c.3979G>A | NM_001354897.1:c.3979G>C | NM_001354897.1:c.3979G>T |
APC transcript variant 15 | NM_001354906.2:c.3100= | NM_001354906.2:c.3100G>A | NM_001354906.2:c.3100G>C | NM_001354906.2:c.3100G>T |
APC transcript variant 15 | NM_001354906.1:c.3100= | NM_001354906.1:c.3100G>A | NM_001354906.1:c.3100G>C | NM_001354906.1:c.3100G>T |
APC transcript variant 5 | NM_001354896.2:c.4003= | NM_001354896.2:c.4003G>A | NM_001354896.2:c.4003G>C | NM_001354896.2:c.4003G>T |
APC transcript variant 5 | NM_001354896.1:c.4003= | NM_001354896.1:c.4003G>A | NM_001354896.1:c.4003G>C | NM_001354896.1:c.4003G>T |
APC transcript variant 7 | NM_001354898.2:c.3874= | NM_001354898.2:c.3874G>A | NM_001354898.2:c.3874G>C | NM_001354898.2:c.3874G>T |
APC transcript variant 7 | NM_001354898.1:c.3874= | NM_001354898.1:c.3874G>A | NM_001354898.1:c.3874G>C | NM_001354898.1:c.3874G>T |
APC transcript variant 8 | NM_001354899.2:c.3865= | NM_001354899.2:c.3865G>A | NM_001354899.2:c.3865G>C | NM_001354899.2:c.3865G>T |
APC transcript variant 8 | NM_001354899.1:c.3865= | NM_001354899.1:c.3865G>A | NM_001354899.1:c.3865G>C | NM_001354899.1:c.3865G>T |
APC transcript variant 9 | NM_001354900.2:c.3826= | NM_001354900.2:c.3826G>A | NM_001354900.2:c.3826G>C | NM_001354900.2:c.3826G>T |
APC transcript variant 9 | NM_001354900.1:c.3826= | NM_001354900.1:c.3826G>A | NM_001354900.1:c.3826G>C | NM_001354900.1:c.3826G>T |
APC transcript variant 11 | NM_001354902.2:c.3676= | NM_001354902.2:c.3676G>A | NM_001354902.2:c.3676G>C | NM_001354902.2:c.3676G>T |
APC transcript variant 11 | NM_001354902.1:c.3676= | NM_001354902.1:c.3676G>A | NM_001354902.1:c.3676G>C | NM_001354902.1:c.3676G>T |
APC transcript variant 10 | NM_001354901.2:c.3772= | NM_001354901.2:c.3772G>A | NM_001354901.2:c.3772G>C | NM_001354901.2:c.3772G>T |
APC transcript variant 10 | NM_001354901.1:c.3772= | NM_001354901.1:c.3772G>A | NM_001354901.1:c.3772G>C | NM_001354901.1:c.3772G>T |
APC transcript variant 12 | NM_001354903.2:c.3646= | NM_001354903.2:c.3646G>A | NM_001354903.2:c.3646G>C | NM_001354903.2:c.3646G>T |
APC transcript variant 12 | NM_001354903.1:c.3646= | NM_001354903.1:c.3646G>A | NM_001354903.1:c.3646G>C | NM_001354903.1:c.3646G>T |
APC transcript variant 13 | NM_001354904.2:c.3571= | NM_001354904.2:c.3571G>A | NM_001354904.2:c.3571G>C | NM_001354904.2:c.3571G>T |
APC transcript variant 13 | NM_001354904.1:c.3571= | NM_001354904.1:c.3571G>A | NM_001354904.1:c.3571G>C | NM_001354904.1:c.3571G>T |
APC transcript variant 14 | NM_001354905.2:c.3469= | NM_001354905.2:c.3469G>A | NM_001354905.2:c.3469G>C | NM_001354905.2:c.3469G>T |
APC transcript variant 14 | NM_001354905.1:c.3469= | NM_001354905.1:c.3469G>A | NM_001354905.1:c.3469G>C | NM_001354905.1:c.3469G>T |
APC transcript variant 33 | NM_001407470.1:c.3100= | NM_001407470.1:c.3100G>A | NM_001407470.1:c.3100G>C | NM_001407470.1:c.3100G>T |
APC transcript variant 17 | NM_001407447.1:c.4003= | NM_001407447.1:c.4003G>A | NM_001407447.1:c.4003G>C | NM_001407447.1:c.4003G>T |
APC transcript variant 22 | NM_001407452.1:c.3919= | NM_001407452.1:c.3919G>A | NM_001407452.1:c.3919G>C | NM_001407452.1:c.3919G>T |
APC transcript variant 16 | NM_001407446.1:c.4033= | NM_001407446.1:c.4033G>A | NM_001407446.1:c.4033G>C | NM_001407446.1:c.4033G>T |
APC transcript variant 35 | NM_001407472.1:c.2797= | NM_001407472.1:c.2797G>A | NM_001407472.1:c.2797G>C | NM_001407472.1:c.2797G>T |
APC transcript variant 37 | NR_176366.1:n.4203= | NR_176366.1:n.4203G>A | NR_176366.1:n.4203G>C | NR_176366.1:n.4203G>T |
APC transcript variant 18 | NM_001407448.1:c.4003= | NM_001407448.1:c.4003G>A | NM_001407448.1:c.4003G>C | NM_001407448.1:c.4003G>T |
APC transcript variant 19 | NM_001407449.1:c.4003= | NM_001407449.1:c.4003G>A | NM_001407449.1:c.4003G>C | NM_001407449.1:c.4003G>T |
APC transcript variant 20 | NM_001407450.1:c.3949= | NM_001407450.1:c.3949G>A | NM_001407450.1:c.3949G>C | NM_001407450.1:c.3949G>T |
APC transcript variant 26 | NM_001407456.1:c.3700= | NM_001407456.1:c.3700G>A | NM_001407456.1:c.3700G>C | NM_001407456.1:c.3700G>T |
APC transcript variant 30 | NM_001407460.1:c.3646= | NM_001407460.1:c.3646G>A | NM_001407460.1:c.3646G>C | NM_001407460.1:c.3646G>T |
APC transcript variant 21 | NM_001407451.1:c.3928= | NM_001407451.1:c.3928G>A | NM_001407451.1:c.3928G>C | NM_001407451.1:c.3928G>T |
APC transcript variant 23 | NM_001407453.1:c.3772= | NM_001407453.1:c.3772G>A | NM_001407453.1:c.3772G>C | NM_001407453.1:c.3772G>T |
APC transcript variant 32 | NM_001407469.1:c.3562= | NM_001407469.1:c.3562G>A | NM_001407469.1:c.3562G>C | NM_001407469.1:c.3562G>T |
APC transcript variant 34 | NM_001407471.1:c.2797= | NM_001407471.1:c.2797G>A | NM_001407471.1:c.2797G>C | NM_001407471.1:c.2797G>T |
APC transcript variant 27 | NM_001407457.1:c.3700= | NM_001407457.1:c.3700G>A | NM_001407457.1:c.3700G>C | NM_001407457.1:c.3700G>T |
APC transcript variant 25 | NM_001407455.1:c.3700= | NM_001407455.1:c.3700G>A | NM_001407455.1:c.3700G>C | NM_001407455.1:c.3700G>T |
APC transcript variant 28 | NM_001407458.1:c.3646= | NM_001407458.1:c.3646G>A | NM_001407458.1:c.3646G>C | NM_001407458.1:c.3646G>T |
APC transcript variant 29 | NM_001407459.1:c.3646= | NM_001407459.1:c.3646G>A | NM_001407459.1:c.3646G>C | NM_001407459.1:c.3646G>T |
APC transcript variant 36 | NR_176365.1:n.3784= | NR_176365.1:n.3784G>A | NR_176365.1:n.3784G>C | NR_176365.1:n.3784G>T |
APC transcript variant 24 | NM_001407454.1:c.3700= | NM_001407454.1:c.3700G>A | NM_001407454.1:c.3700G>C | NM_001407454.1:c.3700G>T |
APC transcript variant 31 | NM_001407467.1:c.3562= | NM_001407467.1:c.3562G>A | NM_001407467.1:c.3562G>C | NM_001407467.1:c.3562G>T |
adenomatous polyposis coli protein isoform b | NP_000029.2:p.Glu1317= | NP_000029.2:p.Glu1317Lys | NP_000029.2:p.Glu1317Gln | NP_000029.2:p.Glu1317Ter |
adenomatous polyposis coli protein isoform b | NP_001120982.1:p.Glu1317= | NP_001120982.1:p.Glu1317Lys | NP_001120982.1:p.Glu1317Gln | NP_001120982.1:p.Glu1317Ter |
adenomatous polyposis coli protein isoform a | NP_001120983.2:p.Glu1299= | NP_001120983.2:p.Glu1299Lys | NP_001120983.2:p.Glu1299Gln | NP_001120983.2:p.Glu1299Ter |
adenomatous polyposis coli protein isoform b | NP_001341824.1:p.Glu1317= | NP_001341824.1:p.Glu1317Lys | NP_001341824.1:p.Glu1317Gln | NP_001341824.1:p.Glu1317Ter |
adenomatous polyposis coli protein isoform d | NP_001341826.1:p.Glu1327= | NP_001341826.1:p.Glu1327Lys | NP_001341826.1:p.Glu1327Gln | NP_001341826.1:p.Glu1327Ter |
adenomatous polyposis coli protein isoform m | NP_001341835.1:p.Glu1034= | NP_001341835.1:p.Glu1034Lys | NP_001341835.1:p.Glu1034Gln | NP_001341835.1:p.Glu1034Ter |
adenomatous polyposis coli protein isoform c | NP_001341825.1:p.Glu1335= | NP_001341825.1:p.Glu1335Lys | NP_001341825.1:p.Glu1335Gln | NP_001341825.1:p.Glu1335Ter |
adenomatous polyposis coli protein isoform e | NP_001341827.1:p.Glu1292= | NP_001341827.1:p.Glu1292Lys | NP_001341827.1:p.Glu1292Gln | NP_001341827.1:p.Glu1292Ter |
adenomatous polyposis coli protein isoform f | NP_001341828.1:p.Glu1289= | NP_001341828.1:p.Glu1289Lys | NP_001341828.1:p.Glu1289Gln | NP_001341828.1:p.Glu1289Ter |
adenomatous polyposis coli protein isoform g | NP_001341829.1:p.Glu1276= | NP_001341829.1:p.Glu1276Lys | NP_001341829.1:p.Glu1276Gln | NP_001341829.1:p.Glu1276Ter |
adenomatous polyposis coli protein isoform i | NP_001341831.1:p.Glu1226= | NP_001341831.1:p.Glu1226Lys | NP_001341831.1:p.Glu1226Gln | NP_001341831.1:p.Glu1226Ter |
adenomatous polyposis coli protein isoform h | NP_001341830.1:p.Glu1258= | NP_001341830.1:p.Glu1258Lys | NP_001341830.1:p.Glu1258Gln | NP_001341830.1:p.Glu1258Ter |
adenomatous polyposis coli protein isoform j | NP_001341832.1:p.Glu1216= | NP_001341832.1:p.Glu1216Lys | NP_001341832.1:p.Glu1216Gln | NP_001341832.1:p.Glu1216Ter |
adenomatous polyposis coli protein isoform k | NP_001341833.1:p.Glu1191= | NP_001341833.1:p.Glu1191Lys | NP_001341833.1:p.Glu1191Gln | NP_001341833.1:p.Glu1191Ter |
adenomatous polyposis coli protein isoform l | NP_001341834.1:p.Glu1157= | NP_001341834.1:p.Glu1157Lys | NP_001341834.1:p.Glu1157Gln | NP_001341834.1:p.Glu1157Ter |
Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.
No | Submitter | Submission ID | Date (Build) |
---|---|---|---|
1 | HGBASE | ss2421387 | Nov 14, 2000 (89) |
2 | AFFY | ss74817429 | Aug 16, 2007 (128) |
3 | GENEREVIEWS | ss179362417 | Nov 18, 2009 (131) |
4 | CANCER-GENOME | ss181340303 | Jul 04, 2010 (132) |
5 | 1000GENOMES | ss332713746 | May 09, 2011 (134) |
6 | NHLBI-ESP | ss342186071 | May 09, 2011 (134) |
7 | OMIM-CURATED-RECORDS | ss342562993 | Mar 30, 2011 (136) |
8 | 1000GENOMES | ss490908256 | May 04, 2012 (137) |
9 | EXOME_CHIP | ss491369632 | May 04, 2012 (137) |
10 | CLINSEQ_SNP | ss491870793 | May 04, 2012 (137) |
11 | ILLUMINA | ss535271670 | Sep 08, 2015 (146) |
12 | TISHKOFF | ss558625124 | Apr 25, 2013 (138) |
13 | ILLUMINA | ss780839521 | Sep 08, 2015 (146) |
14 | ILLUMINA | ss783522747 | Sep 08, 2015 (146) |
15 | EVA-GONL | ss981972850 | Aug 21, 2014 (142) |
16 | 1000GENOMES | ss1316648344 | Aug 21, 2014 (142) |
17 | EVA_DECODE | ss1591494996 | Apr 01, 2015 (144) |
18 | EVA_UK10K_ALSPAC | ss1613707429 | Apr 01, 2015 (144) |
19 | EVA_UK10K_TWINSUK | ss1656701462 | Apr 01, 2015 (144) |
20 | EVA_EXAC | ss1687906825 | Apr 01, 2015 (144) |
21 | EVA_MGP | ss1711094555 | Apr 01, 2015 (144) |
22 | ILLUMINA | ss1752542550 | Sep 08, 2015 (146) |
23 | ILLUMINA | ss1917792698 | Feb 12, 2016 (147) |
24 | WEILL_CORNELL_DGM | ss1925227140 | Feb 12, 2016 (147) |
25 | ILLUMINA | ss1946152125 | Feb 12, 2016 (147) |
26 | ILLUMINA | ss1958812869 | Feb 12, 2016 (147) |
27 | GENOMED | ss1966658504 | Feb 12, 2016 (147) |
28 | JJLAB | ss2023219933 | Sep 14, 2016 (149) |
29 | HUMAN_LONGEVITY | ss2276957110 | Dec 20, 2016 (150) |
30 | GNOMAD | ss2735155538 | Nov 08, 2017 (151) |
31 | GNOMAD | ss2747430832 | Nov 08, 2017 (151) |
32 | GNOMAD | ss2829156924 | Nov 08, 2017 (151) |
33 | AFFY | ss2985331335 | Nov 08, 2017 (151) |
34 | SWEGEN | ss2997566152 | Nov 08, 2017 (151) |
35 | ILLUMINA | ss3022518239 | Nov 08, 2017 (151) |
36 | ILLUMINA | ss3629312397 | Oct 12, 2018 (152) |
37 | ILLUMINA | ss3629312398 | Oct 12, 2018 (152) |
38 | ILLUMINA | ss3635016456 | Oct 12, 2018 (152) |
39 | ILLUMINA | ss3640723750 | Oct 12, 2018 (152) |
40 | ILLUMINA | ss3644885116 | Oct 12, 2018 (152) |
41 | ILLUMINA | ss3653018268 | Oct 12, 2018 (152) |
42 | ILLUMINA | ss3654103503 | Oct 12, 2018 (152) |
43 | EGCUT_WGS | ss3665466749 | Jul 13, 2019 (153) |
44 | EVA_DECODE | ss3715429938 | Jul 13, 2019 (153) |
45 | ILLUMINA | ss3726259996 | Jul 13, 2019 (153) |
46 | ILLUMINA | ss3744538527 | Jul 13, 2019 (153) |
47 | ILLUMINA | ss3745316670 | Jul 13, 2019 (153) |
48 | PAGE_CC | ss3771223250 | Jul 13, 2019 (153) |
49 | ILLUMINA | ss3772810716 | Jul 13, 2019 (153) |
50 | EVA | ss3824102798 | Apr 26, 2020 (154) |
51 | EVA | ss3825677801 | Apr 26, 2020 (154) |
52 | SGDP_PRJ | ss3862680504 | Apr 26, 2020 (154) |
53 | FSA-LAB | ss3984313021 | Apr 26, 2021 (155) |
54 | EVA | ss3986315306 | Apr 26, 2021 (155) |
55 | TOPMED | ss4673759390 | Apr 26, 2021 (155) |
56 | EVA | ss5237644080 | Oct 17, 2022 (156) |
57 | 1000G_HIGH_COVERAGE | ss5265346010 | Oct 17, 2022 (156) |
58 | EVA | ss5360061432 | Oct 17, 2022 (156) |
59 | HUGCELL_USP | ss5463365950 | Oct 17, 2022 (156) |
60 | 1000G_HIGH_COVERAGE | ss5549735047 | Oct 17, 2022 (156) |
61 | EVA | ss5623891797 | Oct 17, 2022 (156) |
62 | SANFORD_IMAGENETICS | ss5624598203 | Oct 17, 2022 (156) |
63 | SANFORD_IMAGENETICS | ss5638594675 | Oct 17, 2022 (156) |
64 | EVA | ss5835451147 | Oct 17, 2022 (156) |
65 | EVA | ss5847272204 | Oct 17, 2022 (156) |
66 | EVA | ss5848060203 | Oct 17, 2022 (156) |
67 | EVA | ss5848632261 | Oct 17, 2022 (156) |
68 | EVA | ss5895747188 | Oct 17, 2022 (156) |
69 | EVA | ss5935767355 | Oct 17, 2022 (156) |
70 | EVA | ss5967046532 | Oct 17, 2022 (156) |
71 | EVA | ss5979750418 | Oct 17, 2022 (156) |
72 | 1000Genomes | NC_000005.9 - 112175240 | Oct 12, 2018 (152) |
73 | 1000Genomes_30x | NC_000005.10 - 112839543 | Oct 17, 2022 (156) |
74 | The Avon Longitudinal Study of Parents and Children | NC_000005.9 - 112175240 | Oct 12, 2018 (152) |
75 | Genetic variation in the Estonian population | NC_000005.9 - 112175240 | Oct 12, 2018 (152) |
76 | ExAC | NC_000005.9 - 112175240 | Oct 12, 2018 (152) |
77 | gnomAD - Genomes | NC_000005.10 - 112839543 | Apr 26, 2021 (155) |
78 | gnomAD - Exomes | NC_000005.9 - 112175240 | Jul 13, 2019 (153) |
79 | Genome of the Netherlands Release 5 | NC_000005.9 - 112175240 | Apr 26, 2020 (154) |
80 | Medical Genome Project healthy controls from Spanish population | NC_000005.9 - 112175240 | Apr 26, 2020 (154) |
81 | The PAGE Study | NC_000005.10 - 112839543 | Jul 13, 2019 (153) |
82 | Qatari | NC_000005.9 - 112175240 | Apr 26, 2020 (154) |
83 | SGDP_PRJ | NC_000005.9 - 112175240 | Apr 26, 2020 (154) |
84 | TopMed | NC_000005.10 - 112839543 | Apr 26, 2021 (155) |
85 | UK 10K study - Twins | NC_000005.9 - 112175240 | Oct 12, 2018 (152) |
86 | ALFA | NC_000005.10 - 112839543 | Apr 26, 2021 (155) |
87 | ClinVar | RCV000000872.22 | Oct 17, 2022 (156) |
88 | ClinVar | RCV000034389.23 | Oct 17, 2022 (156) |
89 | ClinVar | RCV000035073.25 | Oct 17, 2022 (156) |
90 | ClinVar | RCV000322880.4 | Oct 17, 2022 (156) |
91 | ClinVar | RCV000579405.5 | Oct 17, 2022 (156) |
92 | ClinVar | RCV001353725.2 | Oct 17, 2022 (156) |
93 | ClinVar | RCV001762027.2 | Oct 17, 2022 (156) |
94 | ClinVar | RCV002227982.4 | Oct 17, 2022 (156) |
History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).
Associated ID | History Updated (Build) |
---|---|
rs52811293 | Sep 21, 2007 (128) |
rs137854581 | Mar 28, 2012 (136) |
Submission IDs | Observation SPDI | Canonical SPDI | Source RSIDs |
---|---|---|---|
ss5935767355 | NC_000005.9:112175239:G:A | NC_000005.10:112839542:G:A | |
ss491870793, ss1591494996 | NC_000005.8:112203138:G:C | NC_000005.10:112839542:G:C | (self) |
28307039, 15739842, 11204997, 7906566, 4276386, 6995287, 210315, 7269070, 14697484, 15739842, ss332713746, ss342186071, ss490908256, ss491369632, ss535271670, ss558625124, ss780839521, ss783522747, ss981972850, ss1316648344, ss1613707429, ss1656701462, ss1687906825, ss1711094555, ss1752542550, ss1917792698, ss1925227140, ss1946152125, ss1958812869, ss1966658504, ss2023219933, ss2735155538, ss2747430832, ss2829156924, ss2985331335, ss2997566152, ss3022518239, ss3629312397, ss3629312398, ss3635016456, ss3640723750, ss3644885116, ss3653018268, ss3654103503, ss3665466749, ss3744538527, ss3745316670, ss3772810716, ss3824102798, ss3825677801, ss3862680504, ss3984313021, ss3986315306, ss5360061432, ss5623891797, ss5624598203, ss5638594675, ss5835451147, ss5847272204, ss5848060203, ss5848632261, ss5935767355, ss5967046532, ss5979750418 | NC_000005.9:112175239:G:C | NC_000005.10:112839542:G:C | (self) |
RCV000000872.22, RCV000034389.23, RCV000035073.25, RCV000322880.4, RCV000579405.5, RCV001353725.2, RCV001762027.2, RCV002227982.4, 37260982, 200249433, 444719, 511136947, 8623851249, ss179362417, ss342562993, ss2276957110, ss3715429938, ss3726259996, ss3771223250, ss4673759390, ss5237644080, ss5265346010, ss5463365950, ss5549735047, ss5895747188 | NC_000005.10:112839542:G:C | NC_000005.10:112839542:G:C | (self) |
ss2421387, ss74817429, ss181340303 | NT_034772.6:20489111:G:C | NC_000005.10:112839542:G:C | (self) |
ss5935767355 | NC_000005.9:112175239:G:T | NC_000005.10:112839542:G:T |
Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.
PMID | Title | Author | Year | Journal |
---|---|---|---|---|
8834176 | Germline APC mutation (Gln1317) in a cancer-prone family that does not result in familial adenomatous polyposis. | White S et al. | 1996 | Genes, chromosomes & cancer |
9724771 | The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history. | Frayling IM et al. | 1998 | Proceedings of the National Academy of Sciences of the United States of America |
10737725 | Prevalence of the APC E1317Q variant in colorectal cancer patients. | Popat S et al. | 2000 | Cancer letters |
11001924 | Germline APC variants in patients with multiple colorectal adenomas, with evidence for the particular importance of E1317Q. | Lamlum H et al. | 2000 | Human molecular genetics |
12173026 | Pathogenic mutations and rare variants of the APC gene identified in 75 Belgian patients with familial adenomatous polyposis by fluorescent enzymatic mutation detection (EMD). | Michils G et al. | 2002 | European journal of human genetics |
14578138 | The APC E1317Q variant in adenomatous polyps and colorectal cancers. | Hahnloser D et al. | 2003 | Cancer epidemiology, biomarkers & prevention |
16134147 | Mutations of APC and MYH in unrelated Italian patients with adenomatous polyposis coli. | Aceto G et al. | 2005 | Human mutation |
17119068 | APC E1317Q is not associated with Colorectal Cancer in a population-based case-control study in Northern Israel. | Rozek LS et al. | 2006 | Cancer epidemiology, biomarkers & prevention |
17920230 | The APC E1317Q and I1307K polymorphisms in non-colorectal cancers. | Liberman E et al. | 2007 | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie |
18199528 | Multiple rare nonsynonymous variants in the adenomatous polyposis coli gene predispose to colorectal adenomas. | Azzopardi D et al. | 2008 | Cancer research |
19029688 | APC gene mutations causing familial adenomatous polyposis in Polish patients. | Plawski A et al. | 2008 | Journal of applied genetics |
19474113 | Risk of colorectal neoplasia associated with the adenomatous polyposis coli E1317Q variant. | Hall MJ et al. | 2009 | Annals of oncology |
19701947 | The APC Variant p.Glu1317Gln predisposes to colorectal adenomas by a novel mechanism of relaxing the target for tumorigenic somatic APC mutations. | Dallosso AR et al. | 2009 | Human mutation |
19888426 | Analysis of candidate genes in occurrence and growth of colorectal adenomas. | Olschwang S et al. | 2009 | Journal of oncology |
20301519 | APC-Associated Polyposis Conditions. | Yen T et al. | 1993 | GeneReviews(®) |
21995949 | Increased variance in germline allele-specific expression of APC associates with colorectal cancer. | Curia MC et al. | 2012 | Gastroenterology |
22703879 | Secondary variants in individuals undergoing exome sequencing: screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes. | Johnston JJ et al. | 2012 | American journal of human genetics |
23159591 | APC germline mutations in individuals being evaluated for familial adenomatous polyposis: a review of the Mayo Clinic experience with 1591 consecutive tests. | Kerr SE et al. | 2013 | The Journal of molecular diagnostics |
23576677 | APC polymorphisms and the risk of colorectal neoplasia: a HuGE review and meta-analysis. | Liang J et al. | 2013 | American journal of epidemiology |
24297550 | PATH-SCAN: a reporting tool for identifying clinically actionable variants. | Daneshjou R et al. | 2014 | Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing |
24728327 | Germline variation in cancer-susceptibility genes in a healthy, ancestrally diverse cohort: implications for individual genome sequencing. | Bodian DL et al. | 2014 | PloS one |
25333069 | Disease variants in genomes of 44 centenarians. | Freudenberg-Hua Y et al. | 2014 | Molecular genetics & genomic medicine |
25741868 | Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. | Richards S et al. | 2015 | Genetics in medicine |
26314409 | Association of APC I1307K and E1317Q polymorphisms with colorectal cancer among Egyptian subjects. | Abdel-Malak C et al. | 2016 | Familial cancer |
30581350 | Association between MTHFR 677C>T Polymorphism and Vitamin B12 Deficiency: A Case-control Study. | Al-Batayneh KM et al. | 2018 | Journal of medical biochemistry |
The Flanks tab provides retrieving flanking sequences of a SNP on all molecules that have placements.
Genomic regions, transcripts, and products
Top▲
Help
NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.
NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.